CarMax’s earnings miss is a win in the Fed’s battle against inflation, Jim Cramer says

CarMax’s earnings miss is a win in the Fed’s battle against inflation, Jim Cramer says


CarMax's earnings miss is a win in the Fed's battle against inflation, Jim Cramer says

CNBC’s Jim Cramer on Thursday told investors that used car retailer CarMax’s recent earnings shortfall is good news for the Federal Reserve’s quest to tamp down inflation.

“When you look at this quarter from CarMax, it tells you the Fed’s been incredibly successful at eroding consumer confidence,” he said. “[Fed Chair] Jay Powell doesn’t want people to spend their money on big-ticket items.”

CarMax missed earnings estimates by 43% in its fiscal second quarter results reported on Thursday, citing macroeconomic issues including inflation and soaring interest rates. 

Shares of Carmax tumbled nearly 25%, notching a new 52-week low. The stock also dragged down shares of other used car dealers including Carvana and AutoNation, which fell 20% and 10%, respectively.

One factor that showcases the used car market’s downturn is a decline in vehicle prices, according to Cramer.

The Manheim Used Vehicle Value Index, a pricing trend indicator, has steadily declined this year even as each monthly reading was up from the year before due to earlier price increases. However, it’s likely there’ll be a year-over-year decline in prices next month, he said.

“That represents real progress in the war against inflation,” Cramer said.

He added that while some investors tried to bottom fish in the used car space before CarMax reported its quarter, they should have known better than to do so in the current inflationary environment.

“The used car stocks looked cheap, but that was a trap because they simply can’t meet Wall Street’s earnings estimates in this environment,” he said.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More